Sulfamoylbenzamide derivatives as antiviral agents against HBV infection

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9399619
SERIAL NO

14130140

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Pharmaceutical compositions of the invention comprise sulfamoylbenzamide derivative useful as pregenomic RNA encapsidation inhibitors, useful for the treatment of Hepatitis B virus (HBV) infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DREXEL UNIVERSITY3141 CHESTNUT STREET PHILADELPHIA PA 19104

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Block, Timothy M Doylestown, US 60 486
Guo, Ju-Tao Lansdale, US 20 73
Xu, Xiaodong Doylestown, US 177 1250

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 26, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00